Hologic (HOLX) : Hologic (HOLX) had a healthy money flow of $0.4 million into the stock during the Wednesdays trading session. The value of bullish trades on upticks was $0.58 million, whereas, investors only sold shares worth $0.18 million on downticks. The stock closed the day with an up-down ratio of 3.21.The money flow in the block trades to the tune of $0 million shows that the bulls were dominant, the large players used the weakness in the stock to accumulate it for the long-term. $0 million worth of transactions were on upticks. Hologic (HOLX) stock slid $0.03 intraday and traded at 38.73, a change of -0.08% over previous days close. However, for the week, the company shares are 0.73% compared to previous weeks close.
Shares of Hologic Inc. appreciated by 0.51% during the last five trading days but lost 0.01% on a 4-week basis. Hologic Inc. is up 13.7% in the last 3-month period. Year-to-Date the stock performance stands at 0.09%.
Hologic (HOLX) : Zacks Investment Research ranks Hologic (HOLX) as 2, which is a Buy recommendation. 8 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. A total of 7 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 15 research analysts is 1.93, which indicates as a Buy.
Hologic (NASDAQ:HOLX): stock was range-bound between the intraday low of $38.42 and the intraday high of $38.91 after having opened at $38.87 on Wednesdays session. The stock finally closed in the red at $38.87, a loss of -0.09%. The stock remained in the red for the whole trading day. The total traded volume was 1,247,356 shares. The stock failed to cross $38.91 in Wednesdays trading. The stocks closing price on Thursday was $38.76.
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. The Companys business units are focused on diagnostics, breast health, GYN surgical and skeletal health. The Companys diagnostics products include Aptima family of assays, its ThinPrep system, the Rapid Fetal Fibronectin Test and its Procleix blood screening assays. The Aptima family of assays is used to detect the infectious microorganisms that cause the common sexually transmitted diseases, chlamydia and gonorrhea, certain high-risk strains of human papillomavirus (HPV), and Trichomonas vaginalis, the parasite that causes trichomoniasis. The Companys GYN surgical products include its NovaSure Endometrial Ablation System and its MyoSure Hysteroscopic Tissue Removal System. The skeletal health products include dual-energy X-ray bone densitometry systems, an ultrasound-based osteoporosis assessment product, and its Fluoroscan mini C-arm imaging products.